These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2859029

  • 1. Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell lines.
    Bräutigam M, Kittner B, Herken H.
    Arzneimittelforschung; 1985; 35(1A):277-84. PubMed ID: 2859029
    [Abstract] [Full Text] [Related]

  • 2. Effect of apomorphine, alpha-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cell lines (PC-12 and N1E-115).
    Bräutigam M, Laschinski G, Kittner B, Herken H.
    Biochem Pharmacol; 1985 Apr 01; 34(7):941-7. PubMed ID: 3921032
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tetrahydrobiopterin prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide.
    Kuhn DM, Geddes TJ.
    Mol Pharmacol; 2003 Oct 01; 64(4):946-53. PubMed ID: 14500751
    [Abstract] [Full Text] [Related]

  • 5. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A, Bauer M, Thöny B, Aebischer P.
    J Neurochem; 2005 Jun 01; 93(6):1482-6. PubMed ID: 15935064
    [Abstract] [Full Text] [Related]

  • 6. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
    Bräutigam M, Kittner B, Laschinski G.
    Mol Pharmacol; 1985 Dec 01; 28(6):515-20. PubMed ID: 3935908
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The activity of tyrosine hydroxylase in intact adrenergic neurons of the mouse vas deferens.
    Bjur RA, Weiner N.
    J Pharmacol Exp Ther; 1975 Jul 01; 194(1):9-26. PubMed ID: 239222
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overexpression of V-1 prevents nitric oxide-induced cell death: involvement of enhanced tetrahydrobiopterin biosynthesis.
    Yuyama K, Yamamoto H, Nakamura K, Nishizaki I, Yamakuni T, Song SY, Sora I, Nagatsu T, Yamamoto T.
    J Neurosci Res; 2003 Jun 15; 72(6):716-25. PubMed ID: 12774312
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.
    Jung W, Herken H.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr 15; 339(4):424-32. PubMed ID: 2525671
    [Abstract] [Full Text] [Related]

  • 14. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
    Ugrumov MV, Melnikova VI, Lavrentyeva AV, Kudrin VS, Rayevsky KS.
    Neuroscience; 2004 Apr 15; 124(3):629-35. PubMed ID: 14980733
    [Abstract] [Full Text] [Related]

  • 15. Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling.
    Zhu W, Mantione KJ, Shen L, Cadet P, Esch T, Goumon Y, Bianchi E, Sonetti D, Stefano GB.
    Med Sci Monit; 2005 Nov 15; 11(11):BR397-404. PubMed ID: 16258388
    [Abstract] [Full Text] [Related]

  • 16. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
    Cumming P, Ase A, Kuwabara H, Gjedde A.
    J Cereb Blood Flow Metab; 1998 May 15; 18(5):491-9. PubMed ID: 9591841
    [Abstract] [Full Text] [Related]

  • 17. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
    Yamamoto H, Kamegaya E, Hagino Y, Imai K, Fujikawa A, Tamura K, Enokiya T, Yamamoto T, Takeshima T, Koga H, Uhl GR, Ikeda K, Sora I.
    Neurochem Int; 2007 May 15; 51(2-4):237-44. PubMed ID: 17664021
    [Abstract] [Full Text] [Related]

  • 18. Poststimulation catecholamine synthesis and tyrosine hydroxylase activation in central noradrenergic neurons. I. In vivo stimulation of the locus coeruleus.
    Salzman PM, Roth RH.
    J Pharmacol Exp Ther; 1980 Jan 15; 212(1):64-73. PubMed ID: 6101343
    [Abstract] [Full Text] [Related]

  • 19. PC12 cells: a model system for studying drug effects on dopamine synthesis and release.
    Kittner B, Bräutigam M, Herken H.
    Arch Int Pharmacodyn Ther; 1987 Apr 15; 286(2):181-94. PubMed ID: 2439033
    [Abstract] [Full Text] [Related]

  • 20. Dopamine-releasing action of 6R-L-erythro-tetrahydrobiopterin: analysis of its action site using sepiapterin.
    Koshimura K, Miwa S, Watanabe Y.
    J Neurochem; 1994 Aug 15; 63(2):649-54. PubMed ID: 7518501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.